Medicare billing address
CMS Medicare provider billing file
1034 N 500 WProvo, UT 84604
CMS public data · NPI 1164436507
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Russell W Rhoades, DO
Specialty
Credential
DO
NPI
1164436507
Primary source state
UT
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Russell W Rhoades, DO from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
1034 N 500 WCMS Doctors & Clinicians file
1055 N 500In the 2024 CMS provider billing file, this NPI had 310 Medicare beneficiaries and 5,125 total services. The average beneficiary age was 75, and the average HCC risk score was 1.2.
Total Medicare allowed amount
$187,265.54
Total Medicare payment amount
$147,829.90
Medicare beneficiaries
310
Total services
5,125
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
70%
CMS beneficiary-panel share
Hypertension
65%
CMS beneficiary-panel share
Diabetes
34%
CMS beneficiary-panel share
Chronic kidney disease
27%
CMS beneficiary-panel share
Ischemic heart disease
27%
CMS beneficiary-panel share
Anxiety
24%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 779 | $121.60 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 636 | $15.65 |
| Insertion of needle into vein for collection of blood sample | 335 | $8.65 |
| Blood test, comprehensive group of blood chemicals | 243 | $10.35 |
| Blood test, thyroid stimulating hormone (tsh) | 212 | $16.46 |
| Hemoglobin a1c level | 207 | $9.52 |
| Cyanocobalamin (vitamin b-12) level | 206 | $14.78 |
| Blood test, lipids (cholesterol and triglycerides) | 195 | $13.12 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 194 | $6.34 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 167 | $122.91 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1164436507. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Levothyroxine Sodium | Levothyroxine Sodium | 435 | 1,142.3 | $5,756.41 |
| 2 | Atorvastatin Calcium | Atorvastatin Calcium | 353 | 987.3 | $4,193.48 |
| 3 | Omeprazole | Omeprazole | 287 | 693 | $4,891.93 |
| 4 | Lisinopril | Lisinopril | 268 | 625 | $2,437.33 |
| 5 | Metformin Hcl | Metformin Hcl | 223 | 535.7 | $2,328.36 |
| 6 | Tamsulosin Hcl | Tamsulosin Hcl | 213 | 517.2 | $3,519.48 |
| 7 | Losartan Potassium | Losartan Potassium | 210 | 525.9 | $2,409.18 |
| 8 | Gabapentin | Gabapentin | 209 | 334.1 | $3,384.92 |
| 9 | Celecoxib | Celecoxib | 206 | 335 | $4,644.15 |
| 10 | Amlodipine Besylate | Amlodipine Besylate | 195 | 527 | $1,694.12 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Kansas City University Of Physicians And Surgeons
Graduation year
2002
Group/practice field
Revere Health Pc
Telehealth reported
Not reported
Secondary specialty fields reported by CMS: Internal Medicine.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.